Alan H. Bryce
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Renal cell carcinoma treatment
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Prostate Cancer Treatment and Research 88
- Oncology 69
- PARP inhibition in cancer therapy 21
- Cancer Immunotherapy and Biomarkers 15
- Cancer Treatment and Pharmacology 14
- Co-authors
- Emmanuel S. Antonarakis (9 shared papers)Thai H. Ho (20 shared papers)Christopher Ryan (1 shared paper)Aleksandar Sekulić (3 shared papers)Andrea McNatty (6 shared papers)Angela Dispenzieri (9 shared papers)Robert A. Kyle (8 shared papers)Rafaël Fonseca (7 shared papers)
- Journals
- Journal of Clinical Oncology (77 papers)Annals of Oncology (8 papers)Prostate Cancer and Prostatic Diseases (7 papers)The Prostate (5 papers)Clinical Genitourinary Cancer (4 papers)
- Partner nations
- United StatesUnited KingdomPakistan
In The Last Decade
Alan H. Bryce
157 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 112
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 801
- Cancer Research 413
- Hepatology 106
- Hematology 113
Countries citing papers authored by Alan H. Bryce
This map shows the geographic impact of Alan H. Bryce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan H. Bryce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan H. Bryce more than expected).
Fields of papers citing papers by Alan H. Bryce
This network shows the impact of papers produced by Alan H. Bryce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan H. Bryce. The network helps show where Alan H. Bryce may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan H. Bryce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 150 | |
| 2 | 2015 | 131 | |
| 3 | 2018 | 120 | |
| 4 | 2018 | 112 | |
| 5 | 2019 | 112 | |
| 6 | 2020 | 98 | |
| 7 | 2020 | 81 | |
| 8 | 2008 | 78 | |
| 9 | 2017 | 76 | |
| 10 | 2009 | 71 | |
| 11 | 2019 | 70 | |
| 12 | 2021 | 58 | |
| 13 | 2023 | 58 | |
| 14 | 2011 | 52 | |
| 15 | 2020 | 46 | |
| 16 | 2017 | 43 | |
| 17 | 2018 | 40 | |
| 18 | 2006 | 39 | |
| 19 | 2020 | 35 | |
| 20 | 2019 | 32 |
About Alan H. Bryce
Alan H. Bryce is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Molecular Biology, having authored 176 papers that have together received 2.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (88 papers), Radiopharmaceutical Chemistry and Applications (32 papers), Cancer Genomics and Diagnostics (24 papers), PARP inhibition in cancer therapy (21 papers), Cancer Immunotherapy and Biomarkers (15 papers), Cancer Treatment and Pharmacology (14 papers), Bladder and Urothelial Cancer Treatments (10 papers) and Cancer, Lipids, and Metabolism (9 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.1k citations), Oncology (801 citations), Cancer Research (413 citations), Hepatology (106 citations) and Hematology (113 citations). Alan H. Bryce has collaborated with scholars based in United States, United Kingdom and Pakistan. Frequent co-authors include Emmanuel S. Antonarakis, Thai H. Ho, Christopher Ryan, Aleksandar Sekulić, Andrea McNatty, Angela Dispenzieri, Robert A. Kyle, Rafaël Fonseca, Nicholas J. Vogelzang and Mitesh J. Borad. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Prostate Cancer and Prostatic Diseases, The Prostate and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.